NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Incannex IHL-42X Secures FDA Fast Track for OSA Treatment

Incannex's oral drug (IHL-42X) for serious sleep apnea (OSA) got FDA Fast Track status to speed up its development and potential approval.

Incannex IHL-42X Secures FDA Fast Track for OSA Treatment
Credit: Incannex/Nasdaq
Already have an account? Sign in.
12/03/2025 · 2:40 PM
IXHL
/ Read more

Feed↓

12/08/2025 · 5:07 PM

90% Success: Exicure's Burixafor Helps Myeloma Stem Cell Collection

Exicure shares positive Phase 2 data on burixafor (GPC-100) showing reliable and rapid stem cell mobilization for autologous transplant in multiple myeloma patients, even those with prior challenging therapies.

/ Subscriber only
TERN-701 Shows 64% Response Rate in Hard-to-Treat Leukemia
12/08/2025 · 4:08 PM

TERN-701 Shows 64% Response Rate in Hard-to-Treat Leukemia

Terns Pharmaceuticals (TERN) announces encouraging Phase 1 results for TERN-701, showing 64% response rates in relapsed/refractory chronic myeloid leukemia patients with favorable safety profile.

/ Subscriber only
Google Prepares Two New AI Smart Glasses for 2026
Featured/ 12/08/2025 · 2:32 PM

Google Prepares Two New AI Smart Glasses for 2026

Google is developing two categories of AI-powered smart glasses—one with displays and one audio-focused—set to compete with Meta, Snap, and Apple in 2026.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe